ITRM930154A0 - Uso di terbinafina per il trattamento terapeutico della pneumocistosi. - Google Patents

Uso di terbinafina per il trattamento terapeutico della pneumocistosi.

Info

Publication number
ITRM930154A0
ITRM930154A0 ITRM930154A ITRM930154A ITRM930154A0 IT RM930154 A0 ITRM930154 A0 IT RM930154A0 IT RM930154 A ITRM930154 A IT RM930154A IT RM930154 A ITRM930154 A IT RM930154A IT RM930154 A0 ITRM930154 A0 IT RM930154A0
Authority
IT
Italy
Prior art keywords
pneumocystosis
terbinafine
therapeutic treatment
therapeutic
treatment
Prior art date
Application number
ITRM930154A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Mendes Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendes Srl filed Critical Mendes Srl
Publication of ITRM930154A0 publication Critical patent/ITRM930154A0/it
Priority to ITRM930154A priority Critical patent/IT1261776B/it
Priority to ES94910517T priority patent/ES2178650T3/es
Priority to KR1019950703775A priority patent/KR100343031B1/ko
Priority to JP6519792A priority patent/JPH08508012A/ja
Priority to AT94910517T priority patent/ATE219667T1/de
Priority to US08/525,526 priority patent/US5719192A/en
Priority to CA002157590A priority patent/CA2157590C/en
Priority to PT94910517T priority patent/PT692963E/pt
Priority to DE69430867T priority patent/DE69430867T2/de
Priority to DK94910517T priority patent/DK0692963T3/da
Priority to EP94910517A priority patent/EP0692963B1/en
Priority to PCT/IT1994/000023 priority patent/WO1994020082A1/en
Publication of ITRM930154A1 publication Critical patent/ITRM930154A1/it
Application granted granted Critical
Publication of IT1261776B publication Critical patent/IT1261776B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM930154A 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi. IT1261776B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
CA002157590A CA2157590C (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis
DE69430867T DE69430867T2 (de) 1993-03-12 1994-03-11 Verwendung von terbinafin zur behandlung von pneumocystosis
JP6519792A JPH08508012A (ja) 1993-03-12 1994-03-11 ニューモシスチス症の治療のためのテルビナフィンの使用
AT94910517T ATE219667T1 (de) 1993-03-12 1994-03-11 Verwendung von terbinafin zur behandlung von pneumocystosis
US08/525,526 US5719192A (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis
ES94910517T ES2178650T3 (es) 1993-03-12 1994-03-11 Uso de terbinafina para el tratamiento terapeutico de neumocitosis.
PT94910517T PT692963E (pt) 1993-03-12 1994-03-11 Utilizacao da terbinafina para o tratamento terapeutico da pneumocistose
KR1019950703775A KR100343031B1 (ko) 1993-03-12 1994-03-11 간질형질세포성폐렴의치료방법을위한테르비나핀의사용
DK94910517T DK0692963T3 (da) 1993-03-12 1994-03-11 Anvendelse af terbinafin til terapeutisk behandling af pneumocystose
EP94910517A EP0692963B1 (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis
PCT/IT1994/000023 WO1994020082A1 (en) 1993-03-12 1994-03-11 Use of terbinafine for the therapeutic treatment of pneumocystosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.

Publications (3)

Publication Number Publication Date
ITRM930154A0 true ITRM930154A0 (it) 1993-03-12
ITRM930154A1 ITRM930154A1 (it) 1994-09-12
IT1261776B IT1261776B (it) 1996-06-03

Family

ID=11401596

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930154A IT1261776B (it) 1993-03-12 1993-03-12 Uso di terbinafina per il trattamento terapeutico della pneumocistosi.

Country Status (12)

Country Link
US (1) US5719192A (it)
EP (1) EP0692963B1 (it)
JP (1) JPH08508012A (it)
KR (1) KR100343031B1 (it)
AT (1) ATE219667T1 (it)
CA (1) CA2157590C (it)
DE (1) DE69430867T2 (it)
DK (1) DK0692963T3 (it)
ES (1) ES2178650T3 (it)
IT (1) IT1261776B (it)
PT (1) PT692963E (it)
WO (1) WO1994020082A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003360D0 (en) 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
RU2214237C1 (ru) * 2002-04-24 2003-10-20 Закрытое акционерное общество "Брынцалов-А" Противогрибковое средство "брамизил"
JP2007513199A (ja) 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス，インコーポレイテッド インスリン治療のための薬学的組成物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes

Also Published As

Publication number Publication date
CA2157590C (en) 2006-01-10
EP0692963B1 (en) 2002-06-26
PT692963E (pt) 2002-10-31
ATE219667T1 (de) 2002-07-15
US5719192A (en) 1998-02-17
DE69430867T2 (de) 2003-01-02
CA2157590A1 (en) 1994-09-15
EP0692963A1 (en) 1996-01-24
ES2178650T3 (es) 2003-01-01
IT1261776B (it) 1996-06-03
KR100343031B1 (ko) 2002-11-07
WO1994020082A1 (en) 1994-09-15
DE69430867D1 (de) 2002-08-01
KR960700699A (ko) 1996-02-24
ITRM930154A1 (it) 1994-09-12
JPH08508012A (ja) 1996-08-27
DK0692963T3 (da) 2002-10-14

Similar Documents

Publication Publication Date Title
MX9204301A (es) Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico.
FI906367A0 (fi) Terapeutiska nukleosider.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
FI904854A0 (fi) Terapeutiska nukleosider.
ITMI932412A1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
IT1232822B (it) Impiego di progestina per il trattamento della osteoporosi
ES2152315T3 (es) Xamoneline tartrato.
ITTO920958A1 (it) Doccia per uso terapeutico.
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
ITRM930412A0 (it) Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.
IT8820245A0 (it) Palmitoil_fruttosio_1,6_difosfato, suo uso terapeutico e relativi metodi di preparazione.
ITMI930748A0 (it) Inibitori della trombina, loro preparazione ed uso per applicazioni terapeutiche, profilattiche e diagnostiche
IT1295067B1 (it) Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale
ITMI931800A0 (it) Uso della 4 -desossi-4-iododoxorubicina per il trattamento della alamiloidosi
IT8947916A0 (it) Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoil derivato della d-carnitina
ITRM940072A0 (it) Uso della ribonucleasi seminali per la terapia antimetastatica
KR950008159U (ko) 지압등받이 의자
ITMI920333A1 (it) Uso di sostanze parasimpaticomimetiche dirette per la terapia del dolore.
IT231678Y1 (it) Corsetto per il trattamento della patalogia vertebrale.
IT1229566B (it) Gel di antracicline e loro uso terapeutico.
ES1012288Y (es) Andador perfeccionado para uso ortopedico.
BR9304388A (pt) Composição terapêutica de uso nasal
ES1012287Y (es) Sillita para uso ortopedico.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227